Bondiloxs Topical Hemostatic Granules
K-Number: K161274 · 2017-01-18
ApplicantMedtrade Products , Ltd.
Decision Date2017-01-18
Product CodeQSY
DecisionSubstantially Equivalent
Device Summary
Bondiloxs Topical Hemostatic Granules is a medical device manufactured by Medtrade Products , Ltd.. It received FDA 510(k) clearance on 2017-01-18 under approval number K161274. The device is classified under product code QSY. FDA Decision: Substantially Equivalent.
Frequently Asked Questions
What is the Bondiloxs Topical Hemostatic Granules?
Bondiloxs Topical Hemostatic Granules is a medical device that received FDA 510(k) clearance on 2017-01-18. It is manufactured by Medtrade Products , Ltd.. The 510(k) number is K161274.
When was Bondiloxs Topical Hemostatic Granules approved by the FDA?
Bondiloxs Topical Hemostatic Granules received FDA 510(k) clearance on 2017-01-18, under approval number K161274.
What company makes Bondiloxs Topical Hemostatic Granules?
Bondiloxs Topical Hemostatic Granules is manufactured by Medtrade Products , Ltd..
What is the FDA product code for Bondiloxs Topical Hemostatic Granules?
The FDA product code for Bondiloxs Topical Hemostatic Granules is QSY.
Other Devices by Medtrade Products , Ltd.
Related Devices (Code: QSY)
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.